The growing popularity of GLP-1 drugs comes as the public begins to view obesity as a disease rather than a personal failing, as the Obesity Action Coalition has stated
But there's a quieter, emerging trend gaining traction among physicians and health-optimizing individuals alike: microdosing GLP-1 medications
It received FDA approval in 2016 for moderate-to-severe plaque psoriasis, with subsequent approvals for psoriatic arthritis (2017), ankylosing spondylitis (2019), and non-radiographic axial spondyloarthritis (2020)
Its everything MAHA is all about
Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor bckade
Use the Mifflin-St Jeor formula: multiply your weight in pounds by 10, height in inches by 6.25, subtract your age times 5, then add or subtract 5 for men or women respectively